One thing that helps columnist Tanita Allen ease fear about future symptoms is separating what she can do today from what she ...

Columnist Tanita Allen's mindfulness and meditation practice has taught her that she doesn't need to fight herself every ...

Differences in brain connections for people who carry a mutation known to cause Huntington’s disease are detectable decades before the onset of motor symptoms, a study showed. The findings suggested ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google My wife, Jill, who is gene-positive with Huntington’s disease (HD ...

“Can they tell by looking at me how useless and weak and flimsy and [artificial] (and how foney) I feel?” — notes from Woody Guthrie, dated Aug. 21, 1952 Woody Guthrie was an American ...

Several late-stage clinical trials are now recruiting participants to test whether three experimental oral therapies can slow the progression of Huntington’s disease, with active or planned sites in ...

When I was diagnosed with Huntington’s disease (HD), I thought the hardest part would be the symptoms: the involuntary movements, the mood changes, the balance issues, the unpredictable fatigue. But I ...

A real-world study shows that the approved chorea treatment Austedo (deutetrabenazine) reduces involuntary movements in adults with Huntington’s disease and is generally well tolerated in clinical ...

Atalanta Therapeutics has raised $97 million to support planned Phase 1 clinical trials of its experimental RNA interference (RNAi)-based therapies for Huntington’s disease and a genetic form of ...

The first participant has been dosed in a large clinical trial testing the experimental oral therapy votoplam (formerly PTC518) in adults with early-stage Huntington’s disease. The Novartis-sponsored ...

There is no cure for Huntington’s disease, nor have any disease-modifying therapies been developed yet that can stop its progression. However, there are approved treatments that can help patients ...

SOM Biotech is preparing to launch a global late-stage clinical trial to evaluate whether SOM3355, its experimental oral therapy, can safely and effectively ease movement problems and other symptoms ...